E Silva, B.* , Daubry, A.* , Faville, C.* , De Voeght, A., Foguenne, J., Jassin, M., Kwan, O., Correia Da Cruz, L., Carriglio, G., Charles, S., Baron, F., Caers, J., Gothot, A., & Ehx, G. (2026). Biases introduced by Ficoll-based isolation in acute myeloid leukemia sample analyses support the use of hemolysis. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/342923. doi:10.64898/2026.02.11.705243 * These authors have contributed equally to this work. |
E Silva, B.* , Daubry, A.* , Faville, C.* , De Voeght, A., Foguenne, J., Jassin, M., Kwan, O., Correia Da Cruz, L., Carriglio, G., Charles, S., Baron, F., Caers, J., Gothot, A., & Ehx, G. (2026). Biases introduced by Ficoll-based isolation in acute myeloid leukemia sample analyses support the use of hemolysis. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/341505. * These authors have contributed equally to this work. |
Faville, C., E Silva, B., Daubry, A., Correia Da Cruz, L., Carriglio, G., Charles, S., De Voeght, A., Fleron, M., Baiwir, D., Mazzucchelli, G., Fillet, M., Willems, L., Baron, F., & Ehx, G. (January 2026). Characterization of Immunogenic MHC-I epitopes presentation in acute myeloid leukemia drug-tolerant persisters [Paper presentation]. Televie Seminar 2026. |
Faville, C., E Silva, B., Daubry, A., Correia Da Cruz, L., Carriglio, G., Charles, S., Baiwir, D., Fleron, M., Mazzucchelli, G., De Voeght, A., Willems, L., Fillet, M., Baron, F., & Ehx, G. (November 2025). Characterization of Immunogenic MHC-I epitopes presentation in acute myeloid leukemia drug-tolerant persisters [Poster presentation]. BIS congress. |
Faville, C.* , E Silva, B.* , Baron, F., & Ehx, G. (19 March 2025). Use of Human Acute Myeloid Leukemia Cells to Study Graft-Versus-Leukemia Immunity in Xenogeneic Mouse Models of Graft-Versus-Host Disease. Methods in Molecular Biology, 2907, 359 - 375. doi:10.1007/978-1-0716-4430-0_17 * These authors have contributed equally to this work. |
Faville, C., E Silva, B., Vilanova Mana, L., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M., Willems, L., & Ehx, G. (18 March 2025). Optimization Of An MHC-I immunoprecipitation Protocol For Mass Spectrometry Analyses Of Persister-Specific Antigens In Acute Myeloid Leukemia [Poster presentation]. EACR Conference "Persister Cells: from Bacteria to Cancer". |
E Silva, B., Daubry, A., Faville, C., Jassin, M., Charles, S., Dubois, S., Baron, F., & Ehx, G. (2025). IFN-γ predisposes acute myeloid leukemia to therapy resistance [Poster presentation]. EACR Conference Persister Cells: from Bacteria to Cancer. |
Faville, C., E Silva, B., Cobraiville, G., Ehx, G., Fillet, M., Baron, F., De Voeght, A., Vilanova Mana, L., Willems, L., Baiwir, D., & Mazzucchelli, G. (October 2024). Optimization of an MHC-I immunoprecipitation protocol for mass spectrometry analyses of persister-specific antigens in acute myeloid leukemia [Paper presentation]. yBIS: 1st annual meeting. |
Faville, C., E Silva, B., Vilanova Mana, L., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M., Mazzucchelli, G., Ehx, G., Baiwir, D., & Willems, L. (September 2024). Optimization Of An MHC-I immunoprecipitation Protocol For Mass Spectrometry Analyses Of Persister-Specific Antigens In Acute Myeloid Leukemia [Poster presentation]. GIGA Day. |
E Silva, B., Daubry, A., Faville, C., Jassin, M., Baron, F., & Ehx, G. (2024). IFN-γ predisposes acute myeloid leukemia to therapy resistance. European Journal of Immunology. doi:10.1002/eji.202470200 |
E Silva, B., Daubry, A., Faville, C., Jassin, M., Baron, F., & Ehx, G. (2024). IFN-γ predisposes acute myeloid leukemia to therapy resistance [Paper presentation]. EDT-Immunology PhD Day. |
Faville, C., E Silva, B., Baron, F., & Ehx, G. (2024). Use of human AML cells to study graft-versus-leukemia immunity in xenogeneic mouse models of GVHD. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/320359. doi:10.1101/2024.04.30.591828 |
Faville, C.* , E Silva, B.* , Jassin, M., DUBOIS, S., Daulne, C., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M.* , & Ehx, G.*. (06 February 2024). Discovery And Targeting of Persister-specific Antigens in Acute Myeloid Leukemia [Paper presentation]. Télévie Seminar. * These authors have contributed equally to this work. |
Faville, C.* , E Silva, B.* , Jassin, M., DUBOIS, S., Daulne, C., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M.* , & Ehx, G.*. (06 February 2024). Discovery And Targeting of Persister-specific Antigens in Acute Myeloid Leukemia [Poster presentation]. Télévie Seminar. * These authors have contributed equally to this work. |
E Silva, B., Daubry, A., Faville, C., Jassin, M., Baron, F., & Ehx, G. (2024). IFN-γ predisposes acute myeloid leukemia to therapy resistance [Poster presentation]. yBIS First Annual Meeting. |
E Silva, B., Daubry, A., Faville, C., Jassin, M., Baron, F., & Ehx, G. (2024). IFN-γ predisposes acute myeloid leukemia to therapy resistance [Poster presentation]. GIGA Day 2024. |
E Silva, B., Faville, C., Jassin, M., DUBOIS, S., De Voeght, A., Baron, F., & Ehx, G. (09 September 2023). Characterizing the immune recognition of chemo-persister blasts in acute myeloid leukemia [Poster presentation]. GIGA Day 2023. |
Faville, C., Nix, C., Baron, F., Ehx, G., & Fillet, M. (02 February 2022). Discovery of tumor-specific antigens presented by diapaused acute myeloid leukemia (AML) cells using ion-mobility mass spectrometry [Paper presentation]. CIRM-Day. |